- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-24-mer
- Ligands
- 24 x EXJ: (3R)-3-(3-chlorophenyl)-3-[(5-methyl-7-oxo-6,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)amino]propanenitrile(Non-covalent)
- 84 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 7 residues within 4Å:- Chain A: S.39, P.40, S.41
- Chain I: E.134, R.137, H.138
- Ligands: EXJ.1
Ligand excluded by PLIPSO4.3: 4 residues within 4Å:- Chain A: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.4: 6 residues within 4Å:- Chain A: G.9, T.10, K.42, R.88
- Ligands: EXJ.1, DMS.5
Ligand excluded by PLIPSO4.6: 3 residues within 4Å:- Chain A: R.24, S.121, K.122
Ligand excluded by PLIPSO4.8: 7 residues within 4Å:- Chain B: S.39, P.40, S.41
- Chain L: E.134, R.137, H.138
- Ligands: EXJ.7
Ligand excluded by PLIPSO4.9: 4 residues within 4Å:- Chain B: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.10: 6 residues within 4Å:- Chain B: G.9, T.10, K.42, R.88
- Ligands: EXJ.7, DMS.11
Ligand excluded by PLIPSO4.12: 3 residues within 4Å:- Chain B: R.24, S.121, K.122
Ligand excluded by PLIPSO4.14: 7 residues within 4Å:- Chain C: S.39, P.40, S.41
- Chain J: E.134, R.137, H.138
- Ligands: EXJ.13
Ligand excluded by PLIPSO4.15: 4 residues within 4Å:- Chain C: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.16: 6 residues within 4Å:- Chain C: G.9, T.10, K.42, R.88
- Ligands: EXJ.13, DMS.17
Ligand excluded by PLIPSO4.18: 3 residues within 4Å:- Chain C: R.24, S.121, K.122
Ligand excluded by PLIPSO4.20: 7 residues within 4Å:- Chain D: S.39, P.40, S.41
- Chain K: E.134, R.137, H.138
- Ligands: EXJ.19
Ligand excluded by PLIPSO4.21: 4 residues within 4Å:- Chain D: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.22: 6 residues within 4Å:- Chain D: G.9, T.10, K.42, R.88
- Ligands: EXJ.19, DMS.23
Ligand excluded by PLIPSO4.24: 3 residues within 4Å:- Chain D: R.24, S.121, K.122
Ligand excluded by PLIPSO4.26: 7 residues within 4Å:- Chain A: E.134, R.137, H.138
- Chain E: S.39, P.40, S.41
- Ligands: EXJ.25
Ligand excluded by PLIPSO4.27: 4 residues within 4Å:- Chain E: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.28: 6 residues within 4Å:- Chain E: G.9, T.10, K.42, R.88
- Ligands: EXJ.25, DMS.29
Ligand excluded by PLIPSO4.30: 3 residues within 4Å:- Chain E: R.24, S.121, K.122
Ligand excluded by PLIPSO4.32: 7 residues within 4Å:- Chain D: E.134, R.137, H.138
- Chain F: S.39, P.40, S.41
- Ligands: EXJ.31
Ligand excluded by PLIPSO4.33: 4 residues within 4Å:- Chain F: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.34: 6 residues within 4Å:- Chain F: G.9, T.10, K.42, R.88
- Ligands: EXJ.31, DMS.35
Ligand excluded by PLIPSO4.36: 3 residues within 4Å:- Chain F: R.24, S.121, K.122
Ligand excluded by PLIPSO4.38: 7 residues within 4Å:- Chain B: E.134, R.137, H.138
- Chain G: S.39, P.40, S.41
- Ligands: EXJ.37
Ligand excluded by PLIPSO4.39: 4 residues within 4Å:- Chain G: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.40: 6 residues within 4Å:- Chain G: G.9, T.10, K.42, R.88
- Ligands: EXJ.37, DMS.41
Ligand excluded by PLIPSO4.42: 3 residues within 4Å:- Chain G: R.24, S.121, K.122
Ligand excluded by PLIPSO4.44: 7 residues within 4Å:- Chain C: E.134, R.137, H.138
- Chain H: S.39, P.40, S.41
- Ligands: EXJ.43
Ligand excluded by PLIPSO4.45: 4 residues within 4Å:- Chain H: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.46: 6 residues within 4Å:- Chain H: G.9, T.10, K.42, R.88
- Ligands: EXJ.43, DMS.47
Ligand excluded by PLIPSO4.48: 3 residues within 4Å:- Chain H: R.24, S.121, K.122
Ligand excluded by PLIPSO4.50: 7 residues within 4Å:- Chain E: E.134, R.137, H.138
- Chain I: S.39, P.40, S.41
- Ligands: EXJ.49
Ligand excluded by PLIPSO4.51: 4 residues within 4Å:- Chain I: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.52: 6 residues within 4Å:- Chain I: G.9, T.10, K.42, R.88
- Ligands: EXJ.49, DMS.53
Ligand excluded by PLIPSO4.54: 3 residues within 4Å:- Chain I: R.24, S.121, K.122
Ligand excluded by PLIPSO4.56: 7 residues within 4Å:- Chain H: E.134, R.137, H.138
- Chain J: S.39, P.40, S.41
- Ligands: EXJ.55
Ligand excluded by PLIPSO4.57: 4 residues within 4Å:- Chain J: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.58: 6 residues within 4Å:- Chain J: G.9, T.10, K.42, R.88
- Ligands: EXJ.55, DMS.59
Ligand excluded by PLIPSO4.60: 3 residues within 4Å:- Chain J: R.24, S.121, K.122
Ligand excluded by PLIPSO4.62: 7 residues within 4Å:- Chain F: E.134, R.137, H.138
- Chain K: S.39, P.40, S.41
- Ligands: EXJ.61
Ligand excluded by PLIPSO4.63: 4 residues within 4Å:- Chain K: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.64: 6 residues within 4Å:- Chain K: G.9, T.10, K.42, R.88
- Ligands: EXJ.61, DMS.65
Ligand excluded by PLIPSO4.66: 3 residues within 4Å:- Chain K: R.24, S.121, K.122
Ligand excluded by PLIPSO4.68: 7 residues within 4Å:- Chain G: E.134, R.137, H.138
- Chain L: S.39, P.40, S.41
- Ligands: EXJ.67
Ligand excluded by PLIPSO4.69: 4 residues within 4Å:- Chain L: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.70: 6 residues within 4Å:- Chain L: G.9, T.10, K.42, R.88
- Ligands: EXJ.67, DMS.71
Ligand excluded by PLIPSO4.72: 3 residues within 4Å:- Chain L: R.24, S.121, K.122
Ligand excluded by PLIPSO4.74: 2 residues within 4Å:- Chain M: S.121, K.122
Ligand excluded by PLIPSO4.75: 4 residues within 4Å:- Chain M: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.76: 4 residues within 4Å:- Chain M: M.74, Y.98, L.102
- Ligands: EXJ.73
Ligand excluded by PLIPSO4.78: 2 residues within 4Å:- Chain N: S.121, K.122
Ligand excluded by PLIPSO4.79: 4 residues within 4Å:- Chain N: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.80: 4 residues within 4Å:- Chain N: M.74, Y.98, L.102
- Ligands: EXJ.77
Ligand excluded by PLIPSO4.82: 2 residues within 4Å:- Chain O: S.121, K.122
Ligand excluded by PLIPSO4.83: 4 residues within 4Å:- Chain O: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.84: 4 residues within 4Å:- Chain O: M.74, Y.98, L.102
- Ligands: EXJ.81
Ligand excluded by PLIPSO4.86: 2 residues within 4Å:- Chain P: S.121, K.122
Ligand excluded by PLIPSO4.87: 4 residues within 4Å:- Chain P: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.88: 4 residues within 4Å:- Chain P: M.74, Y.98, L.102
- Ligands: EXJ.85
Ligand excluded by PLIPSO4.90: 2 residues within 4Å:- Chain Q: S.121, K.122
Ligand excluded by PLIPSO4.91: 4 residues within 4Å:- Chain Q: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.92: 4 residues within 4Å:- Chain Q: M.74, Y.98, L.102
- Ligands: EXJ.89
Ligand excluded by PLIPSO4.94: 2 residues within 4Å:- Chain R: S.121, K.122
Ligand excluded by PLIPSO4.95: 4 residues within 4Å:- Chain R: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.96: 4 residues within 4Å:- Chain R: M.74, Y.98, L.102
- Ligands: EXJ.93
Ligand excluded by PLIPSO4.98: 2 residues within 4Å:- Chain S: S.121, K.122
Ligand excluded by PLIPSO4.99: 4 residues within 4Å:- Chain S: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.100: 4 residues within 4Å:- Chain S: M.74, Y.98, L.102
- Ligands: EXJ.97
Ligand excluded by PLIPSO4.102: 2 residues within 4Å:- Chain T: S.121, K.122
Ligand excluded by PLIPSO4.103: 4 residues within 4Å:- Chain T: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.104: 4 residues within 4Å:- Chain T: M.74, Y.98, L.102
- Ligands: EXJ.101
Ligand excluded by PLIPSO4.106: 2 residues within 4Å:- Chain U: S.121, K.122
Ligand excluded by PLIPSO4.107: 4 residues within 4Å:- Chain U: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.108: 4 residues within 4Å:- Chain U: M.74, Y.98, L.102
- Ligands: EXJ.105
Ligand excluded by PLIPSO4.110: 2 residues within 4Å:- Chain V: S.121, K.122
Ligand excluded by PLIPSO4.111: 4 residues within 4Å:- Chain V: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.112: 4 residues within 4Å:- Chain V: M.74, Y.98, L.102
- Ligands: EXJ.109
Ligand excluded by PLIPSO4.114: 2 residues within 4Å:- Chain W: S.121, K.122
Ligand excluded by PLIPSO4.115: 4 residues within 4Å:- Chain W: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.116: 4 residues within 4Å:- Chain W: M.74, Y.98, L.102
- Ligands: EXJ.113
Ligand excluded by PLIPSO4.118: 2 residues within 4Å:- Chain X: S.121, K.122
Ligand excluded by PLIPSO4.119: 4 residues within 4Å:- Chain X: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.120: 4 residues within 4Å:- Chain X: M.74, Y.98, L.102
- Ligands: EXJ.117
Ligand excluded by PLIP- 12 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.5: 5 residues within 4Å:- Chain A: Y.7, P.8, R.88, G.89
- Ligands: SO4.4
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:G.89
- Salt bridges: A:E.99
DMS.11: 5 residues within 4Å:- Chain B: Y.7, P.8, R.88, G.89
- Ligands: SO4.10
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:G.89
- Salt bridges: B:E.99
DMS.17: 5 residues within 4Å:- Chain C: Y.7, P.8, R.88, G.89
- Ligands: SO4.16
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:G.89
- Salt bridges: C:E.99
DMS.23: 5 residues within 4Å:- Chain D: Y.7, P.8, R.88, G.89
- Ligands: SO4.22
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:G.89
- Salt bridges: D:E.99
DMS.29: 5 residues within 4Å:- Chain E: Y.7, P.8, R.88, G.89
- Ligands: SO4.28
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:G.89
- Salt bridges: E:E.99
DMS.35: 5 residues within 4Å:- Chain F: Y.7, P.8, R.88, G.89
- Ligands: SO4.34
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:G.89
- Salt bridges: F:E.99
DMS.41: 5 residues within 4Å:- Chain G: Y.7, P.8, R.88, G.89
- Ligands: SO4.40
2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:G.89
- Salt bridges: G:E.99
DMS.47: 5 residues within 4Å:- Chain H: Y.7, P.8, R.88, G.89
- Ligands: SO4.46
2 PLIP interactions:2 interactions with chain H- Hydrogen bonds: H:G.89
- Salt bridges: H:E.99
DMS.53: 5 residues within 4Å:- Chain I: Y.7, P.8, R.88, G.89
- Ligands: SO4.52
2 PLIP interactions:2 interactions with chain I- Hydrogen bonds: I:G.89
- Salt bridges: I:E.99
DMS.59: 5 residues within 4Å:- Chain J: Y.7, P.8, R.88, G.89
- Ligands: SO4.58
2 PLIP interactions:2 interactions with chain J- Hydrogen bonds: J:G.89
- Salt bridges: J:E.99
DMS.65: 5 residues within 4Å:- Chain K: Y.7, P.8, R.88, G.89
- Ligands: SO4.64
2 PLIP interactions:2 interactions with chain K- Hydrogen bonds: K:G.89
- Salt bridges: K:E.99
DMS.71: 5 residues within 4Å:- Chain L: Y.7, P.8, R.88, G.89
- Ligands: SO4.70
2 PLIP interactions:2 interactions with chain L- Hydrogen bonds: L:G.89
- Salt bridges: L:E.99
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Skepper, C.K. et al., Discovery and Optimization of Phosphopantetheine Adenylyltransferase Inhibitors with Gram-Negative Antibacterial Activity. J. Med. Chem. (2018)
- Release Date
- 2018-04-04
- Peptides
- Phosphopantetheine adenylyltransferase: ABCDEFGHIJKLMNOPQRSTUVWX
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
BC
BD
BE
BF
BG
BH
BI
BJ
BK
BL
BM
AN
AO
AP
AQ
AR
AS
AT
AU
AV
AW
AX
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-24-mer
- Ligands
- 24 x EXJ: (3R)-3-(3-chlorophenyl)-3-[(5-methyl-7-oxo-6,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)amino]propanenitrile(Non-covalent)
- 84 x SO4: SULFATE ION(Non-functional Binders)
- 12 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Skepper, C.K. et al., Discovery and Optimization of Phosphopantetheine Adenylyltransferase Inhibitors with Gram-Negative Antibacterial Activity. J. Med. Chem. (2018)
- Release Date
- 2018-04-04
- Peptides
- Phosphopantetheine adenylyltransferase: ABCDEFGHIJKLMNOPQRSTUVWX
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
BC
BD
BE
BF
BG
BH
BI
BJ
BK
BL
BM
AN
AO
AP
AQ
AR
AS
AT
AU
AV
AW
AX
A